Compared to PBS group, mice treated with chemotherapies (CPT‐11, SCR/SN38‐NP and In‐si/SN38‐NP) exhibited continued tumor growth, while those receiving DDR1‐silencing combined strategy (si/SN38‐NP) achieved nearly complete tumor eradication (Figure 7C). This evidence concerns the gene DDR1 and neoplasm.